JAMA:接受机械通气的严重中风患者,早期与标准方法的气管切开对功能恢复的影响

2022-05-12 网络 网络

在接受机械通气的严重中风患者中,早期气管切开的策略与标准的气管切开方法相比,并没有明显改善6个月后无严重残疾的存活率。

许多严重中风患者的气道保护性反射功能受损,导致有创机械通气时间过长。尽管一般危重病人中有15%最终需要气管切开,但在对急性脑损伤(如严重中风)病人的研究中,气管切开率高达35%。

为了检验早期气管插管与标准气管插管是否能改善接受机械通气的中风患者的功能结局,来自德国海德堡大学的学者开展了一项随机临床试验,纳入382名接受有创通气的严重急性缺血性或出血性卒中患者被随机分配(1:1)到早期气管切开术(插管≤5天)或正在进行的呼吸机断流术,结果发表在近期JAMA上。

患者在26个美国和德国的神经重症监护中心被随机分配。患者被分配到早期气管插管策略(n = 188)或标准气管插管(对照组)策略(n = 194)。主要结果是6个月时的功能结果,根据改良的Rankin量表评分(0-6),将0(无残疾)至4(中度残疾)与5(严重残疾)或6(死亡)进行二分法计算。

结果显示,在382名随机患者中(中位年龄59岁;49.8%为女性),366名(95.8%)完成了试验,并有主要结果的随访数据(早期组177名患者[94.1%];标准组189名患者[97.4%])。早期气管切开组中95.2%的患者在插管后4天内(IQR,3-4天)进行了气管切开(主要是经皮),对照组中67%的患者在插管后11天内(IQR,10-12天)。

早期气管插管组与对照组相比,6个月时没有严重残疾(mRS评分,0-4)的比例没有显著差异(43.5% vs 47.1%;差异,-3.6% [95% CI,-14.3%至7.2%];OR=0.93 [95% CI,0.60-1.42];P = 0.73)。在严重不良事件中,早期气管切开组有5.0%(121个报告事件中的6个),而3.4%(118个报告事件中的4个)与气管切开有关。

在接受机械通气的严重中风患者中,早期气管切开的策略与标准的气管切开方法相比,并没有明显改善6个月后无严重残疾的存活率。然而,效果估计值周围的置信区间较宽,可能包括了临床上的重要差异,因此不能排除早期气管切开策略带来的临床相关益处或危害。

 

参考文献:

Effect of Early vs Standard Approach to Tracheostomy on Functional Outcome at 6 Months Among Patients With Severe Stroke Receiving Mechanical Ventilation: The SETPOINT2 Randomized Clinical Trial. JAMA. Published online May 04, 2022. doi:10.1001/jama.2022.4798

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2008983, encodeId=be6920089835a, content=<a href='/topic/show?id=7cde63830dc' target=_blank style='color:#2F92EE;'>#气管切开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63830, encryptionId=7cde63830dc, topicName=气管切开)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Dec 28 04:18:35 CST 2022, time=2022-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218991, encodeId=a8921218991d8, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a><a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习), TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Thu May 12 10:28:49 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218990, encodeId=7ec9121899027, content=不错的进展,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Thu May 12 10:28:36 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538131, encodeId=538415381310a, content=<a href='/topic/show?id=e835226210e' target=_blank style='color:#2F92EE;'>#中风患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22621, encryptionId=e835226210e, topicName=中风患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b5612933772, createdName=sunylz, createdTime=Thu May 12 01:18:35 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599359, encodeId=a09815993597a, content=<a href='/topic/show?id=5eb4329159a' target=_blank style='color:#2F92EE;'>#功能恢复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32915, encryptionId=5eb4329159a, topicName=功能恢复)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e9518693674, createdName=mnda, createdTime=Thu May 12 01:18:35 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243499, encodeId=638b1243499d6, content=JAMA上文章都是顶级的,谢谢williamhill asia 及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Tue May 10 13:18:35 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2008983, encodeId=be6920089835a, content=<a href='/topic/show?id=7cde63830dc' target=_blank style='color:#2F92EE;'>#气管切开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63830, encryptionId=7cde63830dc, topicName=气管切开)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Dec 28 04:18:35 CST 2022, time=2022-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218991, encodeId=a8921218991d8, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a><a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习), TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Thu May 12 10:28:49 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218990, encodeId=7ec9121899027, content=不错的进展,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Thu May 12 10:28:36 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538131, encodeId=538415381310a, content=<a href='/topic/show?id=e835226210e' target=_blank style='color:#2F92EE;'>#中风患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22621, encryptionId=e835226210e, topicName=中风患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b5612933772, createdName=sunylz, createdTime=Thu May 12 01:18:35 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599359, encodeId=a09815993597a, content=<a href='/topic/show?id=5eb4329159a' target=_blank style='color:#2F92EE;'>#功能恢复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32915, encryptionId=5eb4329159a, topicName=功能恢复)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e9518693674, createdName=mnda, createdTime=Thu May 12 01:18:35 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243499, encodeId=638b1243499d6, content=JAMA上文章都是顶级的,谢谢williamhill asia 及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Tue May 10 13:18:35 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2008983, encodeId=be6920089835a, content=<a href='/topic/show?id=7cde63830dc' target=_blank style='color:#2F92EE;'>#气管切开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63830, encryptionId=7cde63830dc, topicName=气管切开)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Dec 28 04:18:35 CST 2022, time=2022-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218991, encodeId=a8921218991d8, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a><a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习), TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Thu May 12 10:28:49 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218990, encodeId=7ec9121899027, content=不错的进展,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Thu May 12 10:28:36 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538131, encodeId=538415381310a, content=<a href='/topic/show?id=e835226210e' target=_blank style='color:#2F92EE;'>#中风患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22621, encryptionId=e835226210e, topicName=中风患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b5612933772, createdName=sunylz, createdTime=Thu May 12 01:18:35 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599359, encodeId=a09815993597a, content=<a href='/topic/show?id=5eb4329159a' target=_blank style='color:#2F92EE;'>#功能恢复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32915, encryptionId=5eb4329159a, topicName=功能恢复)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e9518693674, createdName=mnda, createdTime=Thu May 12 01:18:35 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243499, encodeId=638b1243499d6, content=JAMA上文章都是顶级的,谢谢williamhill asia 及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Tue May 10 13:18:35 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-05-12 ms6000000960504356

    不错的进展,学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2008983, encodeId=be6920089835a, content=<a href='/topic/show?id=7cde63830dc' target=_blank style='color:#2F92EE;'>#气管切开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63830, encryptionId=7cde63830dc, topicName=气管切开)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Dec 28 04:18:35 CST 2022, time=2022-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218991, encodeId=a8921218991d8, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a><a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习), TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Thu May 12 10:28:49 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218990, encodeId=7ec9121899027, content=不错的进展,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Thu May 12 10:28:36 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538131, encodeId=538415381310a, content=<a href='/topic/show?id=e835226210e' target=_blank style='color:#2F92EE;'>#中风患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22621, encryptionId=e835226210e, topicName=中风患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b5612933772, createdName=sunylz, createdTime=Thu May 12 01:18:35 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599359, encodeId=a09815993597a, content=<a href='/topic/show?id=5eb4329159a' target=_blank style='color:#2F92EE;'>#功能恢复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32915, encryptionId=5eb4329159a, topicName=功能恢复)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e9518693674, createdName=mnda, createdTime=Thu May 12 01:18:35 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243499, encodeId=638b1243499d6, content=JAMA上文章都是顶级的,谢谢williamhill asia 及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Tue May 10 13:18:35 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2008983, encodeId=be6920089835a, content=<a href='/topic/show?id=7cde63830dc' target=_blank style='color:#2F92EE;'>#气管切开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63830, encryptionId=7cde63830dc, topicName=气管切开)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Dec 28 04:18:35 CST 2022, time=2022-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218991, encodeId=a8921218991d8, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a><a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习), TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Thu May 12 10:28:49 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218990, encodeId=7ec9121899027, content=不错的进展,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Thu May 12 10:28:36 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538131, encodeId=538415381310a, content=<a href='/topic/show?id=e835226210e' target=_blank style='color:#2F92EE;'>#中风患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22621, encryptionId=e835226210e, topicName=中风患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b5612933772, createdName=sunylz, createdTime=Thu May 12 01:18:35 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599359, encodeId=a09815993597a, content=<a href='/topic/show?id=5eb4329159a' target=_blank style='color:#2F92EE;'>#功能恢复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32915, encryptionId=5eb4329159a, topicName=功能恢复)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e9518693674, createdName=mnda, createdTime=Thu May 12 01:18:35 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243499, encodeId=638b1243499d6, content=JAMA上文章都是顶级的,谢谢williamhill asia 及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Tue May 10 13:18:35 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-05-12 mnda
  6. [GetPortalCommentsPageByObjectIdResponse(id=2008983, encodeId=be6920089835a, content=<a href='/topic/show?id=7cde63830dc' target=_blank style='color:#2F92EE;'>#气管切开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63830, encryptionId=7cde63830dc, topicName=气管切开)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Dec 28 04:18:35 CST 2022, time=2022-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218991, encodeId=a8921218991d8, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a><a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习), TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Thu May 12 10:28:49 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218990, encodeId=7ec9121899027, content=不错的进展,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Thu May 12 10:28:36 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538131, encodeId=538415381310a, content=<a href='/topic/show?id=e835226210e' target=_blank style='color:#2F92EE;'>#中风患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22621, encryptionId=e835226210e, topicName=中风患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b5612933772, createdName=sunylz, createdTime=Thu May 12 01:18:35 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599359, encodeId=a09815993597a, content=<a href='/topic/show?id=5eb4329159a' target=_blank style='color:#2F92EE;'>#功能恢复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32915, encryptionId=5eb4329159a, topicName=功能恢复)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e9518693674, createdName=mnda, createdTime=Thu May 12 01:18:35 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243499, encodeId=638b1243499d6, content=JAMA上文章都是顶级的,谢谢williamhill asia 及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Tue May 10 13:18:35 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-05-10 肿瘤克星

    JAMA上文章都是顶级的,谢谢williamhill asia 及时上新

    0

相关威廉亚洲官网

首项国际前瞻性观察队列研究!烧伤患者的通气实践结果如何?

烧伤病人是否需应用肺保护性通气以及他们是否从中受益尚不清楚。

AJRCCM:新冠肺炎机械通气患者继发细菌性肺炎的患病率?

插管时基于威廉亚洲博彩公司 的经验性抗生素管理导致抗生素过度使用。

AJRCCM:吸入气中加入5%CO2可预防肺动脉结扎猪模型的肺损伤

机械通气可导致左肺动脉结扎的健康猪在48小时内发生双侧肺损伤,而吸入5%二氧化碳可防止肺损伤。

JAMA:体外二氧化碳去除促进极低潮气量机械通气对急性低氧性呼吸衰竭患者预后的影响

在急性低氧性呼吸衰竭患者中,与传统的低潮气量机械通气相比,使用体外二氧化碳去除促进极低潮气量机械通气不能降低患者90天死亡率

Crit Care:危重患者拔管结局的预测

许多因素与通过自主呼吸试验的危重患者的拔管失败相关。稳健的多参数临床评分和/或人工智能算法应基于所选的自变量进行评估,以改进临床情景中对拔管结局的预测效能。

法国MYCOVID研究:COVID-19机械通气患者的真菌感染率高达22%

机械通气的COVID-19患者中,侵袭性肺曲霉菌病和念珠菌血症和高死亡率与pr/pb CAPA相关。

拓展阅读

机械通气关键特性与安全操作

文章介绍了机械通气的关键特性,包括沟通、检查设置、报警管理、设备操作、通气模式等多方面内容,强调保障通气患者安全及各环节的注意事项。

ICU中的个性化治疗:吸氧范例

本文通过分析临床试验的三种方法,介绍了目前有关成人重症患者氧合目标的文献现状。

气道压力释放通气(APRV):开辟犬类难治性高碳酸血症治疗新路径

本文献报道了一例3个月大雄性沙皮犬因疑似非心源性肺水肿导致的严重高碳酸血症,该犬在接受传统压力控制机械通气、支气管扩张剂治疗、吸痰或更换气管插管后,高碳酸血症未见改善。

美国呼吸治疗协会(AARC)临床实践威廉亚洲博彩公司 :成人机械通气撤机时的自主呼吸试验

williamhill asia 提供了四个与执行SBT和呼吸机撤机相关的建议。williamhill asia 的建议应该可以帮助床旁临床医生更快地停止机械通气并拔管成人危重患者。

湿度调节的艺术:如何优化机械通气中的气体加湿

本综述探讨了气体调节在临床实践中的历史演变,从早期的原型到当代的主动和被动加湿系统。

【今日分享】成人机械通气患者雾化吸入管理的最佳证据总结

总结的机械通气患者雾化吸入管理最佳证据,可作为指引用于临床护理。点击立即下载查看!